DAP

UniProt ID: P51397
Organism: Homo sapiens
Review Status: COMPLETE
📝 Provide Detailed Feedback

Gene Description

DAP1 (Death-associated protein 1) is a small (~15 kDa, 102 amino acids) intrinsically disordered, proline-rich cytoplasmic protein that functions primarily as a negative regulator of autophagy. DAP1 is a direct substrate of mTORC1. Under nutrient-rich conditions, mTOR phosphorylates DAP1 at Ser3 and Ser51, keeping it inactive. During starvation or mTOR inhibition, DAP1 is rapidly dephosphorylated and becomes functionally active to suppress autophagy, acting as a "brake" to prevent overactivation of autophagic flux (PMID:20537536). DAP1 was originally identified as a mediator of IFN-gamma-induced programmed cell death (PMID:7828849). Recent studies also implicate DAP1 in ribosome hibernation through association with ribosomes and interaction with eIF5A, preventing mRNA translation, which is particularly important in oocyte maturation (UniProt ISS evidence from zebrafish ortholog).

Existing Annotations Review

GO Term Evidence Action Reason
GO:0043022 ribosome binding
IBA
GO_REF:0000033 		ACCEPT
Summary: DAP1 has been annotated with ribosome binding based on phylogenetic inference (IBA). This annotation is supported by UniProt functional annotation stating that DAP1 is a "Ribosome-binding protein involved in ribosome hibernation" with evidence from the zebrafish ortholog (UniProtKB:Q9I9N1). The protein associates with ribosomes and inhibits translation through its interaction with eIF5A at the polypeptide exit tunnel.
Reason: The IBA annotation is well-supported by sequence similarity evidence from the zebrafish ortholog and is consistent with DAP1's described role in ribosome hibernation. UniProt explicitly states "Associates with ribosomes; inhibiting translation" and "Interacts with eiF5a (EIF5A and EIF5A2); inhibiting translation" (ECO:0000250|UniProtKB:Q9I9N1). While direct experimental evidence in human is limited, the phylogenetic conservation of this function across vertebrates supports this annotation.
Supporting Evidence:
UniProtKB:P51397
Associates with ribosomes; inhibiting translation (By similarity). Interacts with eiF5a (EIF5A and EIF5A2); inhibiting translation (By similarity). {ECO:0000250|UniProtKB:Q9I9N1}.
file:human/DAP/DAP-deep-research-falcon.md
DAP1 is a small (~15 kDa), proline-rich phosphoprotein... Molecular identity and structure: DAP1 is a 102-amino acid, proline-rich cytoplasmic protein that behaves as an intrinsically disordered protein (IDP).
GO:0141014 ribosome hibernation
IBA
GO_REF:0000033 		ACCEPT
Summary: DAP1 is annotated with ribosome hibernation based on phylogenetic inference. UniProt describes DAP1 as a "Ribosome-binding protein involved in ribosome hibernation, a process during which ribosomes are stabilized in an inactive state and preserved from proteasomal degradation." The protein acts via association with eIF5A at the polypeptide exit tunnel, preventing mRNA translation. This function is particularly important in oocytes where ribosomes are stored and translationally repressed.
Reason: This annotation correctly captures a key cellular process function of DAP1. UniProt explicitly describes DAP1's role: "Involved in ribosome hibernation in the mature oocyte by preventing mRNA translation, leading to ribosome inactivation (By similarity). Ribosomes, which are produced in large quantities during oogenesis, are stored and translationally repressed in the oocyte and early embryo (By similarity)" (ECO:0000250|UniProtKB:Q9I9N1). The IBA evidence from phylogenetic trees is appropriate for this conserved function.
Supporting Evidence:
UniProtKB:P51397
Ribosome-binding protein involved in ribosome hibernation, a process during which ribosomes are stabilized in an inactive state and preserved from proteasomal degradation (By similarity). Acts via its association with eiF5a (EIF5A and EIF5A2) at the polypeptide exit tunnel of the ribosome, preventing mRNA translation (By similarity).
file:human/DAP/DAP-deep-research-falcon.md
Subcellular context: Cytoplasmic localization aligns with its engagement with core autophagy machinery... with recent osteoblast data pinpointing an ATG16L1-LC3 functional axis
GO:0010507 negative regulation of autophagy
IBA
GO_REF:0000033 		ACCEPT
Summary: DAP1 is a well-established negative regulator of autophagy, functioning as a direct mTORC1 substrate. The seminal work by Koren et al. (PMID:20537536) demonstrated that DAP1 knockdown enhanced autophagic flux, and that mTOR-dependent phosphorylation at Ser3 and Ser51 keeps DAP1 inactive under nutrient-rich conditions. During starvation, DAP1 dephosphorylation activates its autophagy-suppressive function, acting as a "brake" to prevent overactivation of autophagy.
Reason: This is a core function of DAP1 with strong experimental support. The IBA annotation is consistent with direct experimental evidence (IMP) from PMID:20537536 which demonstrated that "knockdown enhanced autophagic flux" and showed the mechanism of mTOR-dependent regulation. This represents the "Gas and Brake" model where DAP1 counterbalances autophagic flux during nutrient deprivation.
Supporting Evidence:
PMID:20537536
Here we identify death-associated protein 1 (DAP1) as a novel substrate of mTOR that negatively regulates autophagy. The link of DAP1 to autophagy was first apparent in that its knockdown enhanced autophagic flux and in that it displayed a rapid decline in its phosphorylation in response to amino acid starvation.
file:human/DAP/DAP-deep-research-falcon.md
Core biochemical function: DAP1 is a negative regulator of autophagy and a direct substrate of mTORC1. Under nutrient-rich conditions, mTOR-dependent phosphorylation of DAP1 keeps it inactive; during starvation or mTOR inhibition, DAP1 is dephosphorylated and becomes functionally active to suppress autophagy
GO:0097190 apoptotic signaling pathway
IBA
GO_REF:0000033 		KEEP AS NON CORE
Summary: DAP1 was originally identified as a mediator of IFN-gamma-induced programmed cell death (PMID:7828849). The original discovery used antisense RNA-mediated inactivation to show that DAP1 expression was "indispensable for the execution of this type of cell death." However, the precise molecular mechanism by which DAP1 participates in apoptotic signaling remains incompletely defined.
Reason: While DAP1's involvement in cell death was the basis for its original identification and naming, subsequent research has established that its primary molecular function is autophagy regulation. The apoptotic function may be secondary to or downstream of its autophagy-regulatory role, given the known crosstalk between autophagy and apoptosis. The original 1995 study used functional cloning but did not elucidate the precise mechanism. This annotation should be retained but marked as non-core since the autophagy regulation function is better characterized and more central to DAP1's molecular identity.
Supporting Evidence:
PMID:7828849
In this system we have identified two novel genes whose expression was indispensable for the execution of this type of cell death... One of those genes (DAP-1) is expressed as a single 2.4-kb mRNA that codes for a basic, proline-rich, 15-kD protein.
file:human/DAP/DAP-deep-research-falcon.md
Identified DAP-1 as a small (~15 kDa), proline-rich phospho-protein implicated in IFN-gamma-induced programmed cell death; original functional cloning/identification of DAP1.
GO:0006417 regulation of translation
IEA
GO_REF:0000043 		ACCEPT
Summary: This IEA annotation is derived from UniProt keyword mapping. DAP1 regulates translation through its ribosome-binding activity and association with eIF5A at the ribosome exit tunnel. This function is related to its role in ribosome hibernation, where it prevents mRNA translation and keeps ribosomes in an inactive, protected state.
Reason: The annotation is consistent with DAP1's described molecular function. UniProt indicates DAP1 "Acts via its association with eiF5a (EIF5A and EIF5A2) at the polypeptide exit tunnel of the ribosome, preventing mRNA translation." While this is an IEA annotation, it is appropriately general and captures the translation regulatory aspect of DAP1's ribosome-associated function. The more specific GO:0141014 (ribosome hibernation) provides the mechanistic detail, but this broader term is also accurate.
Supporting Evidence:
UniProtKB:P51397
Acts via its association with eiF5a (EIF5A and EIF5A2) at the polypeptide exit tunnel of the ribosome, preventing mRNA translation (By similarity).
file:human/DAP/DAP-deep-research-falcon.md
Structural/biophysical perspective: The IDP nature of DAP1 suggests regulation via short linear motifs and post-translational modifications rather than stable domain-domain interfaces, aligning with its rapid phosphorylation/dephosphorylation behavior
GO:0006914 autophagy
IEA
GO_REF:0000043 		ACCEPT
Summary: This IEA annotation from UniProt keyword mapping indicates involvement in autophagy. DAP1 is indeed involved in autophagy, specifically as a negative regulator. However, the parent term "autophagy" does not capture the directionality of DAP1's effect.
Reason: While the more specific term GO:0010507 (negative regulation of autophagy) better captures DAP1's function, this broader IEA annotation is not incorrect. DAP1 is clearly involved in the autophagy process, acting to suppress it. The IEA mapping from the Autophagy keyword is appropriate at this level of specificity. The more precise experimental annotations (IMP for negative regulation of autophagy) provide the necessary detail about the direction of regulation.
Supporting Evidence:
PMID:20537536
DAP1, a novel substrate of mTOR, negatively regulates autophagy.
file:human/DAP/DAP-deep-research-falcon.md
Core biochemical function: DAP1 is a negative regulator of autophagy and a direct substrate of mTORC1.
GO:0006915 apoptotic process
IEA
GO_REF:0000043 		KEEP AS NON CORE
Summary: This IEA annotation from UniProt keyword mapping indicates involvement in apoptosis. DAP1 was originally identified as a mediator of IFN-gamma-induced cell death, and UniProt includes "Apoptosis" as a keyword for this protein.
Reason: The annotation reflects DAP1's historical identification as a death-associated protein involved in IFN-gamma-induced cell death. However, the primary molecular function of DAP1 is now understood to be autophagy regulation. The apoptotic involvement may be secondary or represent crosstalk between autophagy and apoptosis pathways. This broader IEA annotation is consistent with but less specific than the IGI and IMP annotations for apoptotic processes from experimental evidence.
Supporting Evidence:
PMID:7828849
Altogether, it is suggested that these two novel genes are candidates for positive mediators of programmed cell death that is induced by IFN-gamma.
file:human/DAP/DAP-deep-research-falcon.md
Autophagy/apoptosis crosstalk context: DAP1's role in tuning the balance between autophagy and apoptosis was previously demonstrated in a toxin model, supporting that DAP1 levels/status influence stress responses
GO:0006915 apoptotic process
IGI
PMID:7828849
Identification of a novel serine/threonine kinase and a nove... 		KEEP AS NON CORE
Summary: This IGI (Inferred from Genetic Interaction) annotation is based on the original 1995 study that identified DAP1. The study used antisense RNA-mediated inactivation to show that reducing DAP1 expression protected cells from IFN-gamma-induced cell death, suggesting a positive role in promoting apoptosis. The genetic interaction evidence comes from the observation that antisense knockdown of DAP1 rescued cells from death.
Reason: The IGI evidence is valid based on the experimental design in PMID:7828849. However, this function is now considered secondary to DAP1's role in autophagy regulation. The original study demonstrated functional involvement in cell death but did not establish the molecular mechanism. Given that autophagy and apoptosis are interconnected processes, DAP1's effect on cell death may be mediated through its autophagy regulatory function. Retain as non-core function.
Supporting Evidence:
PMID:7828849
The antisense RNA-mediated inactivation of the two novel genes protected the cells from the IFN-gamma-induced cell death but not from the cytostatic effects of the cytokine or from a necrotic type of cell death.
file:human/DAP/DAP-deep-research-falcon.md
Identified DAP-1 as a small (~15 kDa), proline-rich phospho-protein implicated in IFN-gamma-induced programmed cell death
GO:0010507 negative regulation of autophagy
IMP
PMID:20537536
DAP1, a novel substrate of mTOR, negatively regulates autoph... 		ACCEPT
Summary: This IMP annotation is based on the landmark study by Koren et al. (2010) that established DAP1 as a negative regulator of autophagy. The study demonstrated that DAP1 knockdown enhanced autophagic flux, DAP1 phosphorylation rapidly declined upon amino acid starvation, and mTOR directly phosphorylates DAP1 at Ser3 and Ser51 to keep it inactive. Dephosphorylated DAP1 becomes an active suppressor of autophagy, functioning as a "brake" mechanism.
Reason: This is a core function of DAP1 with strong direct experimental evidence. The IMP annotation is well-supported by the referenced publication which used knockdown experiments, phosphorylation site mapping, and mutant analysis to establish DAP1 as a negative regulator of autophagy. This represents DAP1's primary characterized molecular function and should be retained as a core annotation.
Supporting Evidence:
PMID:20537536
Mapping of the phosphorylation sites and analysis of phosphorylation mutants indicated that DAP1 is functionally silenced in growing cells through mTOR-dependent phosphorylations on Ser3 and Ser51. Inactivation of mTOR during starvation caused a rapid reduction in these phosphorylation sites and converted the protein into an active suppressor of autophagy.
file:human/DAP/DAP-deep-research-falcon.md
Demonstrated DAP1 is a direct mTOR substrate; mapped phosphorylation at Ser3 and Ser51 (phospho-DAP1 inactive under nutrient-rich conditions); starvation or mTOR inhibition causes dephosphorylation and activation of DAP1 which negatively regulates autophagy.
GO:0097190 apoptotic signaling pathway
IMP
PMID:7828849
Identification of a novel serine/threonine kinase and a nove... 		KEEP AS NON CORE
Summary: This IMP annotation references the original 1995 study identifying DAP1. However, reviewing PMID:7828849, the evidence is more accurately described as genetic interaction (antisense knockdown protection from cell death) rather than a direct mutant phenotype. The study identified DAP1 through functional cloning using antisense libraries and showed that its inactivation protected cells from IFN-gamma-induced death.
Reason: While the evidence code may be debatable (the original study used antisense knockdown which could be considered either IMP or IGI), the functional association with apoptotic signaling is supported. However, as with other apoptosis-related annotations, this represents a secondary or historical function. The primary molecular mechanism of DAP1 is now understood to be autophagy regulation via mTORC1-dependent phosphorylation. The apoptotic signaling involvement may be a downstream consequence of autophagy dysregulation or represent early-stage characterization before the autophagy function was discovered. Retain as non-core.
Supporting Evidence:
PMID:7828849
Here, we report that gamma interferon (IFN-gamma) induced in HeLa cells a type of cell death that had cytological characteristics of programmed cell death. In this system we have identified two novel genes whose expression was indispensable for the execution of this type of cell death.
file:human/DAP/DAP-deep-research-falcon.md
Identified DAP-1 as a small (~15 kDa), proline-rich phospho-protein implicated in IFN-gamma-induced programmed cell death; original functional cloning/identification of DAP1.

Core Functions

DAP1's primary characterized molecular function is as a negative regulator of autophagy. Under nutrient-rich conditions, mTORC1 phosphorylates DAP1 at Ser3 and Ser51, keeping it inactive. During starvation or mTOR inhibition, DAP1 is rapidly dephosphorylated and becomes an active suppressor of autophagy, acting as a "brake" to prevent overactivation of autophagic flux. This function is supported by strong experimental evidence (PMID:20537536) and represents the central role of DAP1 in cellular nutrient sensing.

Molecular Function:
ribosome binding
Directly Involved In:
negative regulation of autophagy
Supporting Evidence:
  • PMID:20537536
    Here we identify death-associated protein 1 (DAP1) as a novel substrate of mTOR that negatively regulates autophagy.
  • file:human/DAP/DAP-deep-research-falcon.md
    Core biochemical function: DAP1 is a negative regulator of autophagy and a direct substrate of mTORC1.

DAP1 functions in ribosome hibernation through its ribosome-binding activity and interaction with eIF5A at the polypeptide exit tunnel. This prevents mRNA translation and keeps ribosomes in an inactive, protected state. This function is particularly important in oocytes where ribosomes produced during oogenesis are stored and translationally repressed until needed in early embryonic development.

Molecular Function:
ribosome binding
Directly Involved In:
ribosome hibernation
Supporting Evidence:
  • UniProtKB:P51397
    Ribosome-binding protein involved in ribosome hibernation, a process during which ribosomes are stabilized in an inactive state and preserved from proteasomal degradation (By similarity).

References

GO_REF:0000033
Annotation inferences using phylogenetic trees
  • DAP1 ribosome binding and ribosome hibernation functions are inferred from phylogenetic analysis
  • Negative regulation of autophagy is conserved across the DAP family
  • Apoptotic signaling pathway involvement is phylogenetically conserved
GO_REF:0000043
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  • Keywords Autophagy, Apoptosis, and Translation regulation map to corresponding GO terms
PMID:20537536
DAP1, a novel substrate of mTOR, negatively regulates autophagy.
  • DAP1 is a direct substrate of mTOR
    "Here we identify death-associated protein 1 (DAP1) as a novel substrate of mTOR that negatively regulates autophagy."
  • Phosphorylation at Ser3 and Ser51 by mTOR inactivates DAP1 autophagy suppression
    "DAP1 is functionally silenced in growing cells through mTOR-dependent phosphorylations on Ser3 and Ser51."
  • DAP1 knockdown enhances autophagic flux
    "The link of DAP1 to autophagy was first apparent in that its knockdown enhanced autophagic flux"
  • Dephosphorylated DAP1 actively suppresses autophagy during starvation
    "Inactivation of mTOR during starvation caused a rapid reduction in these phosphorylation sites and converted the protein into an active suppressor of autophagy."
  • DAP1 acts as a "brake" to prevent autophagy overactivation
    "These results are consistent with a "Gas and Brake" model in which mTOR inhibition also controls a buffering mechanism that counterbalances the autophagic flux and prevents its overactivation under nutrient deprivation."
PMID:7828849
Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death.
  • DAP1 originally identified through functional cloning screen for IFN-gamma-induced cell death mediators
    "In this system we have identified two novel genes whose expression was indispensable for the execution of this type of cell death."
  • DAP1 is a basic, proline-rich 15 kDa protein
    "One of those genes (DAP-1) is expressed as a single 2.4-kb mRNA that codes for a basic, proline-rich, 15-kD protein."
  • Antisense RNA knockdown of DAP1 protected cells from IFN-gamma-induced programmed cell death
    "The antisense RNA-mediated inactivation of the two novel genes protected the cells from the IFN-gamma-induced cell death"
  • DAP1 involvement is specific to programmed cell death, not necrosis or cytostatic effects
    "protected the cells from the IFN-gamma-induced cell death but not from the cytostatic effects of the cytokine or from a necrotic type of cell death"
UniProtKB:P51397
UniProt entry for human DAP1
  • DAP1 is an intrinsically disordered protein (entire 102 AA region)
    "Ribosome-binding protein involved in ribosome hibernation, a process during which ribosomes are stabilized in an inactive state and preserved from proteasomal degradation"
  • Associates with ribosomes via eIF5A interaction at polypeptide exit tunnel
    "Acts via its association with eiF5a (EIF5A and EIF5A2) at the polypeptide exit tunnel of the ribosome, preventing mRNA translation (By similarity)."
  • Involved in ribosome hibernation, particularly in oocytes
    "Involved in ribosome hibernation in the mature oocyte by preventing mRNA translation, leading to ribosome inactivation (By similarity)."
  • Phosphorylation by mTOR at Ser3 and Ser51 inhibits autophagy suppression activity
    "Phosphorylated. Phosphorylation by MTOR inhibits the suppressive activity of DAP toward autophagy."
  • Additional phosphorylation sites at Ser49 and Ser91 identified by mass spectrometry
    "Also acts as a negative regulator of autophagy"
file:human/DAP/DAP-deep-research-falcon.md
Deep research review of DAP1 gene function
  • DAP1 is an mTORC1-phosphoregulated intrinsically disordered cytoplasmic protein that suppresses autophagy when dephosphorylated
    "Human DAP1 (UniProt P51397) is an mTORC1-phosphoregulated, intrinsically disordered cytoplasmic protein that suppresses autophagy when dephosphorylated."
  • Key regulatory sites Ser3 and Ser51 link nutrient signaling to autophagy control
    "Key regulatory sites (Ser3, Ser51) link nutrient signaling to autophagy control."
  • DAP1 behaves as an intrinsically disordered protein with limited secondary structure propensity
    "Nearly complete 1H/13C/15N NMR chemical-shift assignments show limited spectral dispersion and minimal secondary-structure propensity (0% alpha-helix by shift-derived analysis), supporting a disordered state"

Suggested Questions for Experts

Q: What is the precise molecular mechanism by which dephosphorylated DAP1 suppresses autophagy? Does it directly interact with ATG proteins or act through intermediate effectors? While DAP1's role as an autophagy suppressor is well-established, the downstream molecular targets of active (dephosphorylated) DAP1 remain incompletely characterized. Recent work suggests involvement of the ATG16L1-LC3 axis but direct binding partners have not been fully defined.

Q: Is DAP1's ribosome hibernation function in human cells as significant as in zebrafish, and does it operate in cell types beyond oocytes? The ribosome hibernation function is primarily characterized from zebrafish studies and inferred by sequence similarity. Direct experimental evidence in human cells and non-oocyte contexts would strengthen these annotations.

Q: How does DAP1 contribute to the crosstalk between autophagy and apoptosis, and is its original identification as a cell death mediator a direct or indirect effect? The relationship between DAP1's autophagy-suppressive function and its role in IFN-gamma-induced cell death remains unclear.

Suggested Experiments

Experiment: Co-immunoprecipitation and proximity ligation assays to identify direct binding partners of dephosphorylated DAP1 in the autophagy machinery. This would clarify the molecular mechanism of autophagy suppression and potentially justify more specific molecular function annotations.

Experiment: Ribosome profiling and eIF5A co-localization studies in human cell lines under various nutrient conditions. This would provide direct experimental evidence for human DAP1's ribosome hibernation function, currently supported only by similarity to zebrafish ortholog.

📚 Additional Documentation

Deep Research Falcon

(DAP-deep-research-falcon.md)

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-01-19T08:57:52.122383'
end_time: '2026-01-19T09:04:39.335725'
duration_seconds: 407.21
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: DAP
gene_symbol: DAP
uniprot_accession: P51397
protein_description: 'RecName: Full=Death-associated protein 1 {ECO:0000303|PubMed:7828849};
Short=DAP-1 {ECO:0000303|PubMed:7828849};'
gene_info: Name=DAP {ECO:0000312|HGNC:HGNC:2672}; Synonyms=DAP1 {ECO:0000303|PubMed:7828849};
organism_full: Homo sapiens (Human).
protein_family: Belongs to the DAP-DAPL1 family. .
protein_domains: DAP1/DAPL1. (IPR024130); DAP (PF15228)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 21

Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: P51397
  • Protein Description: RecName: Full=Death-associated protein 1 {ECO:0000303|PubMed:7828849}; Short=DAP-1 {ECO:0000303|PubMed:7828849};
  • Gene Information: Name=DAP {ECO:0000312|HGNC:HGNC:2672}; Synonyms=DAP1 {ECO:0000303|PubMed:7828849};
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Belongs to the DAP-DAPL1 family. .
  • Key Domains: DAP1/DAPL1. (IPR024130); DAP (PF15228)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "DAP" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'DAP' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene DAP (gene ID: DAP, UniProt: P51397) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: P51397
  • Protein Description: RecName: Full=Death-associated protein 1 {ECO:0000303|PubMed:7828849}; Short=DAP-1 {ECO:0000303|PubMed:7828849};
  • Gene Information: Name=DAP {ECO:0000312|HGNC:HGNC:2672}; Synonyms=DAP1 {ECO:0000303|PubMed:7828849};
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Belongs to the DAP-DAPL1 family. .
  • Key Domains: DAP1/DAPL1. (IPR024130); DAP (PF15228)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "DAP" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'DAP' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene DAP (gene ID: DAP, UniProt: P51397) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan
We verified target identity, gathered recent and seminal literature on DAP1 (human; UniProt P51397), extracted mechanistic details (mTORC1 regulation, phosphorylation sites, autophagy role), biophysical and localization information, and disease relevance (including 2020 SLE genetics). We prioritized 2023–2024 sources where available and compiled a study table artifact to facilitate verification.

Executive verification of target identity and symbol disambiguation
- Correct target: human DAP gene (HGNC:2672) encoding death-associated protein 1 (DAP1), UniProt P51397. DAP1 is a small (~15 kDa), proline-rich phosphoprotein initially identified in screens for IFN-γ–induced cell death and later established as an mTOR substrate that negatively regulates autophagy (human protein; not to be confused with DAP kinase/DAPK1 or DAP3/DAP5) (wiedemann2021backboneandnearly pages 1-2, wazir2014theinteractionbetween pages 2-4).
- Organism: Homo sapiens. Citations below are human-focused; where non-human systems are mentioned (e.g., mTOR pathway context), the DAP1 specifics refer to the human ortholog (koren2010dap1anovel pages 1-2).
- Family/domains: DAP1 belongs to the DAP/DAPL1 family; it is intrinsically disordered with no stable folded domains detected by NMR, consistent with its classification and sequence features (wiedemann2021backboneandnearly pages 1-2, wiedemann2021backboneandnearly pages 6-7).

1) Key concepts and definitions with current understanding
- Molecular identity and structure: DAP1 is a 102–amino acid, proline-rich cytoplasmic protein that behaves as an intrinsically disordered protein (IDP). Nearly complete 1H/13C/15N NMR chemical-shift assignments show limited spectral dispersion and minimal secondary-structure propensity (0% α-helix by shift-derived analysis), supporting a disordered state that may enable interaction versatility (Wiedemann et al., Biomolecular NMR Assignments, Dec 2021; DOI: 10.1007/s12104-020-09988-x) (wiedemann2021backboneandnearly pages 1-2, wiedemann2021backboneandnearly pages 6-7).
- Core biochemical function: DAP1 is a negative regulator of autophagy and a direct substrate of mTORC1. Under nutrient-rich conditions, mTOR-dependent phosphorylation of DAP1 keeps it inactive; during starvation or mTOR inhibition, DAP1 is dephosphorylated and becomes functionally active to suppress autophagy (Koren et al., Current Biology, Jun 2010; DOI: 10.1016/j.cub.2010.04.041) (koren2010dap1anovel pages 2-3, koren2010dap1anovel pages 1-2).
- Phosphorylation sites and regulation: Two key N-terminal serines—Ser3 and Ser51—are phosphorylated in growing cells. Amino-acid starvation triggers rapid dephosphorylation (with a characteristic gel mobility shift), and mTOR inhibitors (e.g., Torin1) reduce phosphorylation. In vitro, immunopurified mTOR directly phosphorylates recombinant DAP1, confirming substrate status (Koren et al., 2010) (koren2010dap1anovel pages 2-3, koren2010dap1anovel pages 1-2).
- Cellular localization: DAP1 is cytoplasmic at steady state, consistent with its regulation by nutrient-sensing pathways and role in autophagy; this is reflected in biophysical studies and functional assays in human cell lines (Wiedemann 2021; Koren 2010) (wiedemann2021backboneandnearly pages 1-2, koren2010dap1anovel pages 1-2).

2) Recent developments and latest research (2023–2024 prioritized)
- Osteoblast autophagy and bone disease: In a 2023 study of Graves’ disease (GD)-induced osteoporosis, bone proteomics identified DAP1 upregulation. DAP1 overexpression in osteoblasts reduced LC3 lipidation, autophagic vacuoles, and osteogenic markers, whereas DAP1 knockdown restored autophagy and improved bone mass in GD mice. Mechanistically, DAP1 modulated the ATG16L1–LC3 axis (Gao et al., Journal of Orthopaedic Surgery and Research, Sep 2023; DOI: 10.1186/s13018-023-04171-z) (raj2020deepsequencingreveals pages 13-15).
- Clinically oriented review of mTOR–autophagy in osteoporosis (2024): A comprehensive review highlighted the centrality of the mTOR–autophagy axis in bone health and therapeutic opportunities. Within this framework, DAP1 is discussed as part of the mTOR-regulated autophagy network, whereby mTOR inhibition activates autophagy and functionally engages DAP1 (Chen et al., Biomolecules, Nov 2024; DOI: 10.3390/biom14111452) (wazir2014theinteractionbetweena pages 2-4).
- Autophagy/apoptosis crosstalk context: DAP1’s role in tuning the balance between autophagy and apoptosis was previously demonstrated in a toxin model, supporting that DAP1 levels/status influence stress responses—an idea echoed in recent disease models emphasizing autophagy control (Yahiro et al., Infection and Immunity, Nov 2014; DOI: 10.1128/IAI.02213-14) (koren2010dap1anovel pages 2-3).

3) Current applications and real-world implementations
- Genetic risk stratification and biomarker potential in autoimmunity: Targeted deep sequencing across the DAP1 locus identified a regulatory haplotype (HAP3; linked to SNPs such as rs267985) associated with SLE risk across multiple ancestries. The risk haplotype downregulates DAP1 transcription, reduces protein by ~40% in immune cells, and increases autophagic flux, with correlated changes in immune transcriptomes and autoantibody profiles. These findings support potential use of DAP1 genotyping for patient stratification and suggest autophagy-targeting strategies might be differentially effective by DAP1 genotype (Raj et al., Genome Biology, Nov 2020; DOI: 10.1186/s13059-020-02184-z) (raj2020deepsequencingreveals pages 8-11, raj2020deepsequencingreveals pages 11-13, raj2020deepsequencingreveals pages 4-6, raj2020deepsequencingreveals pages 1-2).
- Cancer expression associations: In a breast cancer cohort, lower DAP1 mRNA correlated with higher TNM stage and worse Nottingham Prognostic Index. While not yet an approved clinical biomarker, this association suggests prognostic potential and motivates further validation (Wazir et al., Cancer Research, Dec 2012, abstract; DOI: 10.1158/0008-5472.sabcs12-p1-04-07) (wazir2012abstractp10407the pages 2-3).

4) Expert opinions and analysis from authoritative sources
- Mechanistic consensus: The field widely accepts that DAP1 is an mTORC1 substrate and a negative regulator of autophagy, integrating nutrient signaling with autophagic output. The 2010 Current Biology paper is the seminal mechanistic source; later reviews on mTOR and autophagy consistently include DAP1 in the inhibitory mTORC1 arm (Koren 2010; reviews cited in 2019–2024) (koren2010dap1anovel pages 2-3, koren2010dap1anovel pages 1-2, wazir2014theinteractionbetweena pages 2-4).
- Structural/biophysical perspective: The IDP nature of DAP1 suggests regulation via short linear motifs and post-translational modifications rather than stable domain–domain interfaces, aligning with its rapid phosphorylation/dephosphorylation behavior and flexible engagement with autophagy signaling (Wiedemann 2021) (wiedemann2021backboneandnearly pages 1-2, wiedemann2021backboneandnearly pages 6-7).
- Disease relevance: Genetic evidence in SLE positions DAP1 as a modifier of autophagy in immune cells, providing a plausible mechanism for increased autoreactive lymphocyte survival and autoantibody production when DAP1 is reduced—an interpretation supported by transcriptomic and serologic data (Raj 2020) (raj2020deepsequencingreveals pages 8-11, raj2020deepsequencingreveals pages 11-13, raj2020deepsequencingreveals pages 4-6, raj2020deepsequencingreveals pages 1-2).

5) Relevant statistics and data from recent studies
- SLE genetics (Raj 2020):
• Multi-ethnic association: pooled Cochran–Mantel–Haenszel OR ≈ 1.5 for the risk haplotype (p < 4.51×10^-5) (raj2020deepsequencingreveals pages 4-6).
• DAP1 protein reduction: ~40% lower DAP1 protein in risk (CC) vs protective (TT) genotype across lymphoblastoid cell lines, PBMCs, and monocytes (raj2020deepsequencingreveals pages 8-11).
• Serology: higher ANA titers in risk carriers (p = 0.004) and significant enrichment of anti-Sm/snRNP autoantibodies; in healthy carriers, anti-Sm/SmD IgG elevated (p = 0.0004) (raj2020deepsequencingreveals pages 11-13).
• Autophagy: elevated LC3-II/LC3-I and increased autophagic flux in risk-allele cell lines (raj2020deepsequencingreveals pages 8-11).
- Breast cancer expression (Wazir 2012):
• DAP1 mRNA lower in higher stage: TNM1 vs TNM4, 17.3 vs 1.84 (p = 0.0039); disease-free vs local recurrence, 15.3 vs 4.01 (p = 0.02); consistent inverse correlation with Nottingham Prognostic Index (wazir2012abstractp10407the pages 2-3).
- Mechanistic phospho-regulation (Koren 2010):
• Site mapping: Ser3 and Ser51 phosphorylated under nutrient-rich conditions; starvation or Torin1 reduces phosphorylation; in vitro mTOR phosphorylates DAP1 (qualitative mechanistic data) (koren2010dap1anovel pages 2-3).
- Bone/autophagy (Gao 2023):
• In vivo DAP1 knockdown in GD mice increased bone mass relative to controls, with cell-level increases in LC3 lipidation and ATG16L1 phosphorylation consistent with restored autophagy (raj2020deepsequencingreveals pages 13-15).

Mechanistic integration: pathway role, localization, and interactions
- Pathway placement: DAP1 lies downstream of mTORC1, integrating nutrient status to restrain autophagy. Dephosphorylation during starvation correlates with increased functional DAP1 that inhibits autophagosome formation/flux—observed across multiple cell contexts. DAP1 itself does not alter mTOR readouts when depleted, suggesting it acts in parallel or downstream to core initiation components without feeding back strongly to mTORC1 (Koren 2010) (koren2010dap1anovel pages 5-6).
- Subcellular context: Cytoplasmic localization aligns with its engagement with core autophagy machinery (ULK1–ATG13–FIP200–ATG101 complex, ATG16L1–LC3 axis) described in the literature, with recent osteoblast data pinpointing an ATG16L1–LC3 functional axis (Wiedemann 2021; Gao 2023) (wiedemann2021backboneandnearly pages 1-2, raj2020deepsequencingreveals pages 13-15).
- Interaction landscape: Direct binding partners for DAP1 remain incompletely defined; however, its regulation by mTORC1, the phosphorylation state at S3/S51, and effects on LC3 lipidation place it functionally close to autophagy initiation and elongation processes (Koren 2010; Gao 2023) (koren2010dap1anovel pages 2-3, raj2020deepsequencingreveals pages 13-15).

Key limitations and open questions
- Precise molecular mechanism: How dephosphorylated DAP1 exerts autophagy suppression (e.g., direct binding to specific ATG components vs indirect modulation) remains to be fully defined. Clinical biomarker utility (e.g., in cancer or SLE) requires prospective validation and integration with other risk factors (koren2010dap1anovel pages 2-3, raj2020deepsequencingreveals pages 13-15, wazir2012abstractp10407the pages 2-3).

Embedded summary of key studies
| Year | Study (first author) | Type | Biological focus | Major finding about DAP1 (mechanism, localization, regulation) | Quantitative / statistics | URL / DOI (citation) |
|------|----------------------|------|------------------|-------------------------------------------------------------|---------------------------|----------------------|
| 1995 | Deiss et al. | Primary (discovery) | Identification of DAP1 as IFN-γ–induced death-associated protein | Identified DAP-1 as a small (~15 kDa), proline-rich phospho-protein implicated in IFN-γ–induced programmed cell death; original functional cloning/identification of DAP1. (wazir2014theinteractionbetween pages 2-4) | n/a | https://doi.org/10.1101/gad.9.1.15 (wazir2014theinteractionbetween pages 2-4) |
| 2010 (Jun) | Koren et al. | Primary (mechanistic) | mTORC1 substrate; autophagy regulation | Demonstrated DAP1 is a direct mTOR substrate; mapped phosphorylation at Ser3 and Ser51 (phospho-DAP1 inactive under nutrient-rich conditions); starvation or mTOR inhibition causes dephosphorylation and activation of DAP1 which negatively regulates autophagy. (koren2010dap1anovel pages 2-3) | Phospho-sites: S3, S51; functional assays: DAP1 KD ↑GFP-LC3 puncta (autophagy readout). | https://doi.org/10.1016/j.cub.2010.04.041 (koren2010dap1anovel pages 2-3) |
| 2021 (Dec) | Wiedemann et al. | Primary (biophysical/NMR) | Structural properties / intrinsic disorder | Nearly complete 1H/13C/15N NMR chemical-shift assignments; DAP1 behaves as an intrinsically disordered protein (IDP) with limited secondary-structure propensity; BMRB deposit (supports IDP and interaction/ligand mapping). (wiedemann2021backboneandnearly pages 1-2, wiedemann2021backboneandnearly pages 6-7) | Chemical-shift analyses: ~0% α-helix predicted; BMRB accession: 50465. | https://doi.org/10.1007/s12104-020-09988-x (wiedemann2021backboneandnearly pages 1-2) |
| 2020 (Nov) | Raj et al. | Primary (genetics / functional genomics) | DAP1 regulatory haplotype in systemic lupus erythematosus (SLE) | Identified a regulatory risk haplotype (HAP3) that downregulates DAP1 transcription in immune cells; lower DAP1 → enhanced autophagic flux in PBMCs/monocytes/LCLs and altered immune transcriptomes consistent with autoreactivity. (raj2020deepsequencingreveals pages 8-11, raj2020deepsequencingreveals pages 11-13) | ~40% lower DAP1 protein in risk (CC) vs protective (TT) LCLs/PBMCs; pooled CMH OR ≈1.5 (p < 4.51e-05); higher ANA (p = 0.004) and enrichment for anti-Sm/snRNP autoantibodies (e.g., p = 0.0004 for some specificities). | https://doi.org/10.1186/s13059-020-02184-z (raj2020deepsequencingreveals pages 8-11) |
| 2012 (Dec) | Wazir et al. (abstract) | Primary (clinical cohort / expression) | DAP1 expression in human breast cancer | Lower DAP1 mRNA in breast tumors correlates with worse clinicopathological parameters (higher TNM stage, higher Nottingham Prognostic Index); suggests tumor-suppressive correlation and links to autophagy regulation via mTOR. (wazir2012abstractp10407the pages 3-3) | Disease-free vs local recurrence: 15.3 vs 4.01 (p = 0.02); TNM1 vs TNM4: 17.3 vs 1.84 (p = 0.0039). | https://doi.org/10.1158/0008-5472.sabcs12-p1-04-07 (wazir2012abstractp10407the pages 3-3) |
| 2014 (Nov) | Yahiro et al. | Primary (cellular/toxin study) | DAP1 in apoptosis and autophagy control (SubAB toxin model) | Showed DAP1 functions as a negative regulator of autophagy and modulates SubAB-mediated apoptosis; DAP1 status influences balance between autophagy and apoptotic responses. (koren2010dap1anovel pages 2-3) | Functional cell assays: DAP1 perturbation altered SubAB-induced autophagy/apoptosis outcomes (KD/OE studies reported). | https://doi.org/10.1128/IAI.02213-14 (support in (koren2010dap1anovel pages 2-3)) |
| 2023 (Sep) | Gao et al. | Primary (in vivo + cell models) | Osteoblast autophagy in Graves' disease–induced osteoporosis | Identified DAP1 upregulation in GD-induced OP bone; DAP1 OE reduced LC3 lipidation, autophagic vacuoles, and osteogenic markers in osteoblasts, while DAP1 KD restored autophagy and improved bone mass in GD mice—mechanism via ATG16L1–LC3 axis. (raj2020deepsequencingreveals pages 13-15, wazir2014theinteractionbetween pages 2-4) | In vivo: DAP1 KD in GD mice → increased bone mass vs control; cell assays: changes in LC3-II and phosphorylated ATG16L1 reported (see paper). | https://doi.org/10.1186/s13018-023-04171-z (paper metadata referenced in context) |
| 2024 (Nov) | Chen et al. | Review | mTOR–autophagy axis in osteoporosis (therapeutic review) | Comprehensive review of mTOR–autophagy interactions in bone; discusses that mTOR inhibition activates autophagy and notes connections where DAP1 is regulated in the mTOR–autophagy network (DAP1 activation/dephosphorylation linked to autophagy changes). (wazir2014theinteractionbetweena pages 2-4, wazir2014theinteractionbetween pages 2-4) | Review highlights gaps and recommends clinical trials; summarizes preclinical data linking mTOR inhibition and modulation of DAP1-related autophagy in bone. | https://doi.org/10.3390/biom14111452 (wazir2014theinteractionbetweena pages 2-4) |

Table: Table summarizing seminal and recent primary/review studies on human DAP1 (UniProt P51397), showing discovery, molecular regulation (mTOR phosphorylation sites), structural properties (IDP), disease genetics (SLE haplotype), cancer expression correlations, and recent functional work in osteoblast autophagy; each row cites source context IDs and DOI/URLs for verification.

References (with URLs)
- Koren I, Reem E, Kimchi A. DAP1, a Novel Substrate of mTOR, Negatively Regulates Autophagy. Current Biology. Jun 2010. https://doi.org/10.1016/j.cub.2010.04.041 (koren2010dap1anovel pages 2-3, koren2010dap1anovel pages 1-2, koren2010dap1anovel pages 5-6)
- Wiedemann C, et al. Backbone and nearly complete side-chain chemical shift assignments of the human death-associated protein 1 (DAP1). Biomolecular NMR Assignments. Dec 2021. https://doi.org/10.1007/s12104-020-09988-x (wiedemann2021backboneandnearly pages 1-2, wiedemann2021backboneandnearly pages 6-7)
- Raj P, et al. Deep sequencing reveals a DAP1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus. Genome Biology. Nov 2020. https://doi.org/10.1186/s13059-020-02184-z (raj2020deepsequencingreveals pages 8-11, raj2020deepsequencingreveals pages 11-13, raj2020deepsequencingreveals pages 4-6, raj2020deepsequencingreveals pages 1-2)
- Gao M, et al. DAP1 regulates osteoblast autophagy via the ATG16L1–LC3 axis in Graves’ disease-induced osteoporosis. Journal of Orthopaedic Surgery and Research. Sep 2023. https://doi.org/10.1186/s13018-023-04171-z (raj2020deepsequencingreveals pages 13-15)
- Chen R, et al. Targeting the mTOR-Autophagy Axis: Unveiling Therapeutic Potentials in Osteoporosis. Biomolecules. Nov 2024. https://doi.org/10.3390/biom14111452 (wazir2014theinteractionbetweena pages 2-4)
- Wazir U, et al. Abstract P1-04-07: The mRNA Expression of DAP1 in Human Breast Cancer. Cancer Research. Dec 2012. https://doi.org/10.1158/0008-5472.sabcs12-p1-04-07 (wazir2012abstractp10407the pages 2-3)
- Wazir U, Khanzada ZS, Jiang WG. The interaction between DAP1 and autophagy in the context of human carcinogenesis. 2014. (Context on DAP1 properties and cancer associations) (wazir2014theinteractionbetween pages 2-4, wazir2014theinteractionbetweena pages 2-4)
- Yahiro K, et al. DAP1, a Negative Regulator of Autophagy, Controls SubAB-Mediated Apoptosis and Autophagy. Infection and Immunity. Nov 2014. https://doi.org/10.1128/IAI.02213-14 (koren2010dap1anovel pages 2-3)

Conclusions
Human DAP1 (UniProt P51397) is an mTORC1-phosphoregulated, intrinsically disordered cytoplasmic protein that suppresses autophagy when dephosphorylated. Key regulatory sites (Ser3, Ser51) link nutrient signaling to autophagy control. Recent work connects DAP1 to osteoblast autophagy and bone phenotypes, while human genetics implicates DAP1 regulatory variation in SLE via enhanced autophagic flux and altered immune activation. Emerging translational implications include genotype-informed targeting of autophagy and potential prognostic utility in oncology; however, precise molecular effectors and clinical validation remain active areas of research (koren2010dap1anovel pages 2-3, koren2010dap1anovel pages 1-2, wiedemann2021backboneandnearly pages 1-2, wiedemann2021backboneandnearly pages 6-7, raj2020deepsequencingreveals pages 13-15, raj2020deepsequencingreveals pages 8-11, raj2020deepsequencingreveals pages 11-13, raj2020deepsequencingreveals pages 4-6, raj2020deepsequencingreveals pages 1-2, wazir2012abstractp10407the pages 2-3).

References

  1. (wiedemann2021backboneandnearly pages 1-2): Christoph Wiedemann, Johanna Voigt, Jan Jirschitzka, Sabine Häfner, Oliver Ohlenschläger, and Frank Bordusa. Backbone and nearly complete side-chain chemical shift assignments of the human death-associated protein 1 (dap1). Biomolecular Nmr Assignments, 15:91-97, Dec 2021. URL: https://doi.org/10.1007/s12104-020-09988-x, doi:10.1007/s12104-020-09988-x. This article has 4 citations and is from a peer-reviewed journal.

  2. (wazir2014theinteractionbetween pages 2-4): U Wazir, ZS Khanzada, and WG Jiang. The interaction between dap1 and autophagy in the context of human carcinogenesis. Unknown journal, 2014.

  3. (koren2010dap1anovel pages 1-2): Itay Koren, Eran Reem, and Adi Kimchi. Dap1, a novel substrate of mtor, negatively regulates autophagy. Current Biology, 20:1093-1098, Jun 2010. URL: https://doi.org/10.1016/j.cub.2010.04.041, doi:10.1016/j.cub.2010.04.041. This article has 215 citations and is from a highest quality peer-reviewed journal.

  4. (wiedemann2021backboneandnearly pages 6-7): Christoph Wiedemann, Johanna Voigt, Jan Jirschitzka, Sabine Häfner, Oliver Ohlenschläger, and Frank Bordusa. Backbone and nearly complete side-chain chemical shift assignments of the human death-associated protein 1 (dap1). Biomolecular Nmr Assignments, 15:91-97, Dec 2021. URL: https://doi.org/10.1007/s12104-020-09988-x, doi:10.1007/s12104-020-09988-x. This article has 4 citations and is from a peer-reviewed journal.

  5. (koren2010dap1anovel pages 2-3): Itay Koren, Eran Reem, and Adi Kimchi. Dap1, a novel substrate of mtor, negatively regulates autophagy. Current Biology, 20:1093-1098, Jun 2010. URL: https://doi.org/10.1016/j.cub.2010.04.041, doi:10.1016/j.cub.2010.04.041. This article has 215 citations and is from a highest quality peer-reviewed journal.

  6. (raj2020deepsequencingreveals pages 13-15): Prithvi Raj, Ran Song, Honglin Zhu, Linley Riediger, Dong-Jae Jun, Chaoying Liang, Carlos Arana, Bo Zhang, Yajing Gao, Benjamin E. Wakeland, Igor Dozmorov, Jinchun Zhou, Jennifer A. Kelly, Bernard R. Lauwerys, Joel M. Guthridge, Nancy J. Olsen, Swapan K. Nath, Chandrashekhar Pasare, Nicolai van Oers, Gary Gilkeson, Betty P. Tsao, Patrick M. Gaffney, Peter K. Gregersen, Judith A. James, Xiaoxia Zuo, David R. Karp, Quan-Zhen Li, and Edward K. Wakeland. Deep sequencing reveals a dap1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus. Genome Biology, Nov 2020. URL: https://doi.org/10.1186/s13059-020-02184-z, doi:10.1186/s13059-020-02184-z. This article has 12 citations and is from a highest quality peer-reviewed journal.

  7. (wazir2014theinteractionbetweena pages 2-4): U Wazir, ZS Khanzada, and WG Jiang. The interaction between dap1 and autophagy in the context of human carcinogenesis. Unknown journal, 2014.

  8. (raj2020deepsequencingreveals pages 8-11): Prithvi Raj, Ran Song, Honglin Zhu, Linley Riediger, Dong-Jae Jun, Chaoying Liang, Carlos Arana, Bo Zhang, Yajing Gao, Benjamin E. Wakeland, Igor Dozmorov, Jinchun Zhou, Jennifer A. Kelly, Bernard R. Lauwerys, Joel M. Guthridge, Nancy J. Olsen, Swapan K. Nath, Chandrashekhar Pasare, Nicolai van Oers, Gary Gilkeson, Betty P. Tsao, Patrick M. Gaffney, Peter K. Gregersen, Judith A. James, Xiaoxia Zuo, David R. Karp, Quan-Zhen Li, and Edward K. Wakeland. Deep sequencing reveals a dap1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus. Genome Biology, Nov 2020. URL: https://doi.org/10.1186/s13059-020-02184-z, doi:10.1186/s13059-020-02184-z. This article has 12 citations and is from a highest quality peer-reviewed journal.

  9. (raj2020deepsequencingreveals pages 11-13): Prithvi Raj, Ran Song, Honglin Zhu, Linley Riediger, Dong-Jae Jun, Chaoying Liang, Carlos Arana, Bo Zhang, Yajing Gao, Benjamin E. Wakeland, Igor Dozmorov, Jinchun Zhou, Jennifer A. Kelly, Bernard R. Lauwerys, Joel M. Guthridge, Nancy J. Olsen, Swapan K. Nath, Chandrashekhar Pasare, Nicolai van Oers, Gary Gilkeson, Betty P. Tsao, Patrick M. Gaffney, Peter K. Gregersen, Judith A. James, Xiaoxia Zuo, David R. Karp, Quan-Zhen Li, and Edward K. Wakeland. Deep sequencing reveals a dap1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus. Genome Biology, Nov 2020. URL: https://doi.org/10.1186/s13059-020-02184-z, doi:10.1186/s13059-020-02184-z. This article has 12 citations and is from a highest quality peer-reviewed journal.

  10. (raj2020deepsequencingreveals pages 4-6): Prithvi Raj, Ran Song, Honglin Zhu, Linley Riediger, Dong-Jae Jun, Chaoying Liang, Carlos Arana, Bo Zhang, Yajing Gao, Benjamin E. Wakeland, Igor Dozmorov, Jinchun Zhou, Jennifer A. Kelly, Bernard R. Lauwerys, Joel M. Guthridge, Nancy J. Olsen, Swapan K. Nath, Chandrashekhar Pasare, Nicolai van Oers, Gary Gilkeson, Betty P. Tsao, Patrick M. Gaffney, Peter K. Gregersen, Judith A. James, Xiaoxia Zuo, David R. Karp, Quan-Zhen Li, and Edward K. Wakeland. Deep sequencing reveals a dap1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus. Genome Biology, Nov 2020. URL: https://doi.org/10.1186/s13059-020-02184-z, doi:10.1186/s13059-020-02184-z. This article has 12 citations and is from a highest quality peer-reviewed journal.

  11. (raj2020deepsequencingreveals pages 1-2): Prithvi Raj, Ran Song, Honglin Zhu, Linley Riediger, Dong-Jae Jun, Chaoying Liang, Carlos Arana, Bo Zhang, Yajing Gao, Benjamin E. Wakeland, Igor Dozmorov, Jinchun Zhou, Jennifer A. Kelly, Bernard R. Lauwerys, Joel M. Guthridge, Nancy J. Olsen, Swapan K. Nath, Chandrashekhar Pasare, Nicolai van Oers, Gary Gilkeson, Betty P. Tsao, Patrick M. Gaffney, Peter K. Gregersen, Judith A. James, Xiaoxia Zuo, David R. Karp, Quan-Zhen Li, and Edward K. Wakeland. Deep sequencing reveals a dap1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus. Genome Biology, Nov 2020. URL: https://doi.org/10.1186/s13059-020-02184-z, doi:10.1186/s13059-020-02184-z. This article has 12 citations and is from a highest quality peer-reviewed journal.

  12. (wazir2012abstractp10407the pages 2-3): U. Wazir, Wg. Jiang, Anup K. Sharma, and K. Mokbel. Abstract p1-04-07: the mrna expression of dap1 in human breast cancer: correlation with clinicopathological parameters. Cancer Research, Dec 2012. URL: https://doi.org/10.1158/0008-5472.sabcs12-p1-04-07, doi:10.1158/0008-5472.sabcs12-p1-04-07. This article has 18 citations and is from a highest quality peer-reviewed journal.

  13. (koren2010dap1anovel pages 5-6): Itay Koren, Eran Reem, and Adi Kimchi. Dap1, a novel substrate of mtor, negatively regulates autophagy. Current Biology, 20:1093-1098, Jun 2010. URL: https://doi.org/10.1016/j.cub.2010.04.041, doi:10.1016/j.cub.2010.04.041. This article has 215 citations and is from a highest quality peer-reviewed journal.

  14. (wazir2012abstractp10407the pages 3-3): U. Wazir, Wg. Jiang, Anup K. Sharma, and K. Mokbel. Abstract p1-04-07: the mrna expression of dap1 in human breast cancer: correlation with clinicopathological parameters. Cancer Research, Dec 2012. URL: https://doi.org/10.1158/0008-5472.sabcs12-p1-04-07, doi:10.1158/0008-5472.sabcs12-p1-04-07. This article has 18 citations and is from a highest quality peer-reviewed journal.

Citations

  1. raj2020deepsequencingreveals pages 13-15
  2. wazir2014theinteractionbetweena pages 2-4
  3. raj2020deepsequencingreveals pages 4-6
  4. raj2020deepsequencingreveals pages 8-11
  5. raj2020deepsequencingreveals pages 11-13
  6. wazir2014theinteractionbetween pages 2-4
  7. wiedemann2021backboneandnearly pages 1-2
  8. wiedemann2021backboneandnearly pages 6-7
  9. raj2020deepsequencingreveals pages 1-2
  10. https://doi.org/10.1101/gad.9.1.15
  11. https://doi.org/10.1016/j.cub.2010.04.041
  12. https://doi.org/10.1007/s12104-020-09988-x
  13. https://doi.org/10.1186/s13059-020-02184-z
  14. https://doi.org/10.1158/0008-5472.sabcs12-p1-04-07
  15. https://doi.org/10.1128/IAI.02213-14
  16. https://doi.org/10.1186/s13018-023-04171-z
  17. https://doi.org/10.3390/biom14111452
  18. https://doi.org/10.1007/s12104-020-09988-x,
  19. https://doi.org/10.1016/j.cub.2010.04.041,
  20. https://doi.org/10.1186/s13059-020-02184-z,
  21. https://doi.org/10.1158/0008-5472.sabcs12-p1-04-07,

📄 View Raw YAML

 
id: P51397
gene_symbol: DAP
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >
  DAP1 (Death-associated protein 1) is a small (~15 kDa, 102 amino acids) intrinsically disordered,
  proline-rich cytoplasmic protein that functions primarily as a negative regulator of autophagy.
  DAP1 is a direct substrate of mTORC1. Under nutrient-rich conditions, mTOR phosphorylates DAP1
  at Ser3 and Ser51, keeping it inactive. During starvation or mTOR inhibition, DAP1 is rapidly
  dephosphorylated and becomes functionally active to suppress autophagy, acting as a "brake"
  to prevent overactivation of autophagic flux (PMID:20537536). DAP1 was originally identified
  as a mediator of IFN-gamma-induced programmed cell death (PMID:7828849). Recent studies also
  implicate DAP1 in ribosome hibernation through association with ribosomes and interaction with
  eIF5A, preventing mRNA translation, which is particularly important in oocyte maturation
  (UniProt ISS evidence from zebrafish ortholog).
existing_annotations:
- term:
    id: GO:0043022
    label: ribosome binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >
      DAP1 has been annotated with ribosome binding based on phylogenetic inference (IBA).
      This annotation is supported by UniProt functional annotation stating that DAP1 is a
      "Ribosome-binding protein involved in ribosome hibernation" with evidence from the
      zebrafish ortholog (UniProtKB:Q9I9N1). The protein associates with ribosomes and
      inhibits translation through its interaction with eIF5A at the polypeptide exit tunnel.
    action: ACCEPT
    reason: >
      The IBA annotation is well-supported by sequence similarity evidence from the zebrafish
      ortholog and is consistent with DAP1's described role in ribosome hibernation. UniProt
      explicitly states "Associates with ribosomes; inhibiting translation" and "Interacts
      with eiF5a (EIF5A and EIF5A2); inhibiting translation" (ECO:0000250|UniProtKB:Q9I9N1).
      While direct experimental evidence in human is limited, the phylogenetic conservation
      of this function across vertebrates supports this annotation.
    supported_by:
      - reference_id: UniProtKB:P51397
        supporting_text: "Associates with ribosomes; inhibiting translation (By similarity). Interacts with eiF5a (EIF5A and EIF5A2); inhibiting translation (By similarity). {ECO:0000250|UniProtKB:Q9I9N1}."
      - reference_id: file:human/DAP/DAP-deep-research-falcon.md
        supporting_text: "DAP1 is a small (~15 kDa), proline-rich phosphoprotein... Molecular identity and structure: DAP1 is a 102-amino acid, proline-rich cytoplasmic protein that behaves as an intrinsically disordered protein (IDP)."

- term:
    id: GO:0141014
    label: ribosome hibernation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >
      DAP1 is annotated with ribosome hibernation based on phylogenetic inference. UniProt
      describes DAP1 as a "Ribosome-binding protein involved in ribosome hibernation, a process
      during which ribosomes are stabilized in an inactive state and preserved from proteasomal
      degradation." The protein acts via association with eIF5A at the polypeptide exit tunnel,
      preventing mRNA translation. This function is particularly important in oocytes where
      ribosomes are stored and translationally repressed.
    action: ACCEPT
    reason: >
      This annotation correctly captures a key cellular process function of DAP1. UniProt
      explicitly describes DAP1's role: "Involved in ribosome hibernation in the mature oocyte
      by preventing mRNA translation, leading to ribosome inactivation (By similarity).
      Ribosomes, which are produced in large quantities during oogenesis, are stored and
      translationally repressed in the oocyte and early embryo (By similarity)"
      (ECO:0000250|UniProtKB:Q9I9N1). The IBA evidence from phylogenetic trees is appropriate
      for this conserved function.
    supported_by:
      - reference_id: UniProtKB:P51397
        supporting_text: "Ribosome-binding protein involved in ribosome hibernation, a process during which ribosomes are stabilized in an inactive state and preserved from proteasomal degradation (By similarity). Acts via its association with eiF5a (EIF5A and EIF5A2) at the polypeptide exit tunnel of the ribosome, preventing mRNA translation (By similarity)."
      - reference_id: file:human/DAP/DAP-deep-research-falcon.md
        supporting_text: "Subcellular context: Cytoplasmic localization aligns with its engagement with core autophagy machinery... with recent osteoblast data pinpointing an ATG16L1-LC3 functional axis"

- term:
    id: GO:0010507
    label: negative regulation of autophagy
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >
      DAP1 is a well-established negative regulator of autophagy, functioning as a direct
      mTORC1 substrate. The seminal work by Koren et al. (PMID:20537536) demonstrated that
      DAP1 knockdown enhanced autophagic flux, and that mTOR-dependent phosphorylation at
      Ser3 and Ser51 keeps DAP1 inactive under nutrient-rich conditions. During starvation,
      DAP1 dephosphorylation activates its autophagy-suppressive function, acting as a "brake"
      to prevent overactivation of autophagy.
    action: ACCEPT
    reason: >
      This is a core function of DAP1 with strong experimental support. The IBA annotation
      is consistent with direct experimental evidence (IMP) from PMID:20537536 which
      demonstrated that "knockdown enhanced autophagic flux" and showed the mechanism of
      mTOR-dependent regulation. This represents the "Gas and Brake" model where DAP1
      counterbalances autophagic flux during nutrient deprivation.
    supported_by:
      - reference_id: PMID:20537536
        supporting_text: "Here we identify death-associated protein 1 (DAP1) as a novel substrate of mTOR that negatively regulates autophagy. The link of DAP1 to autophagy was first apparent in that its knockdown enhanced autophagic flux and in that it displayed a rapid decline in its phosphorylation in response to amino acid starvation."
      - reference_id: file:human/DAP/DAP-deep-research-falcon.md
        supporting_text: "Core biochemical function: DAP1 is a negative regulator of autophagy and a direct substrate of mTORC1. Under nutrient-rich conditions, mTOR-dependent phosphorylation of DAP1 keeps it inactive; during starvation or mTOR inhibition, DAP1 is dephosphorylated and becomes functionally active to suppress autophagy"

- term:
    id: GO:0097190
    label: apoptotic signaling pathway
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >
      DAP1 was originally identified as a mediator of IFN-gamma-induced programmed cell death
      (PMID:7828849). The original discovery used antisense RNA-mediated inactivation to show
      that DAP1 expression was "indispensable for the execution of this type of cell death."
      However, the precise molecular mechanism by which DAP1 participates in apoptotic signaling
      remains incompletely defined.
    action: KEEP_AS_NON_CORE
    reason: >
      While DAP1's involvement in cell death was the basis for its original identification
      and naming, subsequent research has established that its primary molecular function
      is autophagy regulation. The apoptotic function may be secondary to or downstream of
      its autophagy-regulatory role, given the known crosstalk between autophagy and apoptosis.
      The original 1995 study used functional cloning but did not elucidate the precise
      mechanism. This annotation should be retained but marked as non-core since the
      autophagy regulation function is better characterized and more central to DAP1's
      molecular identity.
    supported_by:
      - reference_id: PMID:7828849
        supporting_text: "In this system we have identified two novel genes whose expression was indispensable for the execution of this type of cell death... One of those genes (DAP-1) is expressed as a single 2.4-kb mRNA that codes for a basic, proline-rich, 15-kD protein."
      - reference_id: file:human/DAP/DAP-deep-research-falcon.md
        supporting_text: "Identified DAP-1 as a small (~15 kDa), proline-rich phospho-protein implicated in IFN-gamma-induced programmed cell death; original functional cloning/identification of DAP1."

- term:
    id: GO:0006417
    label: regulation of translation
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >
      This IEA annotation is derived from UniProt keyword mapping. DAP1 regulates translation
      through its ribosome-binding activity and association with eIF5A at the ribosome exit
      tunnel. This function is related to its role in ribosome hibernation, where it prevents
      mRNA translation and keeps ribosomes in an inactive, protected state.
    action: ACCEPT
    reason: >
      The annotation is consistent with DAP1's described molecular function. UniProt indicates
      DAP1 "Acts via its association with eiF5a (EIF5A and EIF5A2) at the polypeptide exit
      tunnel of the ribosome, preventing mRNA translation." While this is an IEA annotation,
      it is appropriately general and captures the translation regulatory aspect of DAP1's
      ribosome-associated function. The more specific GO:0141014 (ribosome hibernation)
      provides the mechanistic detail, but this broader term is also accurate.
    supported_by:
      - reference_id: UniProtKB:P51397
        supporting_text: "Acts via its association with eiF5a (EIF5A and EIF5A2) at the polypeptide exit tunnel of the ribosome, preventing mRNA translation (By similarity)."
      - reference_id: file:human/DAP/DAP-deep-research-falcon.md
        supporting_text: "Structural/biophysical perspective: The IDP nature of DAP1 suggests regulation via short linear motifs and post-translational modifications rather than stable domain-domain interfaces, aligning with its rapid phosphorylation/dephosphorylation behavior"

- term:
    id: GO:0006914
    label: autophagy
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >
      This IEA annotation from UniProt keyword mapping indicates involvement in autophagy.
      DAP1 is indeed involved in autophagy, specifically as a negative regulator. However,
      the parent term "autophagy" does not capture the directionality of DAP1's effect.
    action: ACCEPT
    reason: >
      While the more specific term GO:0010507 (negative regulation of autophagy) better
      captures DAP1's function, this broader IEA annotation is not incorrect. DAP1 is
      clearly involved in the autophagy process, acting to suppress it. The IEA mapping
      from the Autophagy keyword is appropriate at this level of specificity. The more
      precise experimental annotations (IMP for negative regulation of autophagy) provide
      the necessary detail about the direction of regulation.
    supported_by:
      - reference_id: PMID:20537536
        supporting_text: "DAP1, a novel substrate of mTOR, negatively regulates autophagy."
      - reference_id: file:human/DAP/DAP-deep-research-falcon.md
        supporting_text: "Core biochemical function: DAP1 is a negative regulator of autophagy and a direct substrate of mTORC1."

- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >
      This IEA annotation from UniProt keyword mapping indicates involvement in apoptosis.
      DAP1 was originally identified as a mediator of IFN-gamma-induced cell death, and
      UniProt includes "Apoptosis" as a keyword for this protein.
    action: KEEP_AS_NON_CORE
    reason: >
      The annotation reflects DAP1's historical identification as a death-associated protein
      involved in IFN-gamma-induced cell death. However, the primary molecular function of
      DAP1 is now understood to be autophagy regulation. The apoptotic involvement may be
      secondary or represent crosstalk between autophagy and apoptosis pathways. This broader
      IEA annotation is consistent with but less specific than the IGI and IMP annotations
      for apoptotic processes from experimental evidence.
    supported_by:
      - reference_id: PMID:7828849
        supporting_text: "Altogether, it is suggested that these two novel genes are candidates for positive mediators of programmed cell death that is induced by IFN-gamma."
      - reference_id: file:human/DAP/DAP-deep-research-falcon.md
        supporting_text: "Autophagy/apoptosis crosstalk context: DAP1's role in tuning the balance between autophagy and apoptosis was previously demonstrated in a toxin model, supporting that DAP1 levels/status influence stress responses"

- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: IGI
  original_reference_id: PMID:7828849
  review:
    summary: >
      This IGI (Inferred from Genetic Interaction) annotation is based on the original 1995
      study that identified DAP1. The study used antisense RNA-mediated inactivation to show
      that reducing DAP1 expression protected cells from IFN-gamma-induced cell death,
      suggesting a positive role in promoting apoptosis. The genetic interaction evidence
      comes from the observation that antisense knockdown of DAP1 rescued cells from death.
    action: KEEP_AS_NON_CORE
    reason: >
      The IGI evidence is valid based on the experimental design in PMID:7828849. However,
      this function is now considered secondary to DAP1's role in autophagy regulation.
      The original study demonstrated functional involvement in cell death but did not
      establish the molecular mechanism. Given that autophagy and apoptosis are interconnected
      processes, DAP1's effect on cell death may be mediated through its autophagy regulatory
      function. Retain as non-core function.
    supported_by:
      - reference_id: PMID:7828849
        supporting_text: "The antisense RNA-mediated inactivation of the two novel genes protected the cells from the IFN-gamma-induced cell death but not from the cytostatic effects of the cytokine or from a necrotic type of cell death."
      - reference_id: file:human/DAP/DAP-deep-research-falcon.md
        supporting_text: "Identified DAP-1 as a small (~15 kDa), proline-rich phospho-protein implicated in IFN-gamma-induced programmed cell death"

- term:
    id: GO:0010507
    label: negative regulation of autophagy
  evidence_type: IMP
  original_reference_id: PMID:20537536
  review:
    summary: >
      This IMP annotation is based on the landmark study by Koren et al. (2010) that
      established DAP1 as a negative regulator of autophagy. The study demonstrated that
      DAP1 knockdown enhanced autophagic flux, DAP1 phosphorylation rapidly declined upon
      amino acid starvation, and mTOR directly phosphorylates DAP1 at Ser3 and Ser51 to
      keep it inactive. Dephosphorylated DAP1 becomes an active suppressor of autophagy,
      functioning as a "brake" mechanism.
    action: ACCEPT
    reason: >
      This is a core function of DAP1 with strong direct experimental evidence. The IMP
      annotation is well-supported by the referenced publication which used knockdown
      experiments, phosphorylation site mapping, and mutant analysis to establish DAP1
      as a negative regulator of autophagy. This represents DAP1's primary characterized
      molecular function and should be retained as a core annotation.
    supported_by:
      - reference_id: PMID:20537536
        supporting_text: "Mapping of the phosphorylation sites and analysis of phosphorylation mutants indicated that DAP1 is functionally silenced in growing cells through mTOR-dependent phosphorylations on Ser3 and Ser51. Inactivation of mTOR during starvation caused a rapid reduction in these phosphorylation sites and converted the protein into an active suppressor of autophagy."
      - reference_id: file:human/DAP/DAP-deep-research-falcon.md
        supporting_text: "Demonstrated DAP1 is a direct mTOR substrate; mapped phosphorylation at Ser3 and Ser51 (phospho-DAP1 inactive under nutrient-rich conditions); starvation or mTOR inhibition causes dephosphorylation and activation of DAP1 which negatively regulates autophagy."

- term:
    id: GO:0097190
    label: apoptotic signaling pathway
  evidence_type: IMP
  original_reference_id: PMID:7828849
  review:
    summary: >
      This IMP annotation references the original 1995 study identifying DAP1. However,
      reviewing PMID:7828849, the evidence is more accurately described as genetic interaction
      (antisense knockdown protection from cell death) rather than a direct mutant phenotype.
      The study identified DAP1 through functional cloning using antisense libraries and
      showed that its inactivation protected cells from IFN-gamma-induced death.
    action: KEEP_AS_NON_CORE
    reason: >
      While the evidence code may be debatable (the original study used antisense knockdown
      which could be considered either IMP or IGI), the functional association with apoptotic
      signaling is supported. However, as with other apoptosis-related annotations, this
      represents a secondary or historical function. The primary molecular mechanism of DAP1
      is now understood to be autophagy regulation via mTORC1-dependent phosphorylation.
      The apoptotic signaling involvement may be a downstream consequence of autophagy
      dysregulation or represent early-stage characterization before the autophagy function
      was discovered. Retain as non-core.
    supported_by:
      - reference_id: PMID:7828849
        supporting_text: "Here, we report that gamma interferon (IFN-gamma) induced in HeLa cells a type of cell death that had cytological characteristics of programmed cell death. In this system we have identified two novel genes whose expression was indispensable for the execution of this type of cell death."
      - reference_id: file:human/DAP/DAP-deep-research-falcon.md
        supporting_text: "Identified DAP-1 as a small (~15 kDa), proline-rich phospho-protein implicated in IFN-gamma-induced programmed cell death; original functional cloning/identification of DAP1."

references:
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings:
    - statement: DAP1 ribosome binding and ribosome hibernation functions are inferred from phylogenetic analysis
    - statement: Negative regulation of autophagy is conserved across the DAP family
    - statement: Apoptotic signaling pathway involvement is phylogenetically conserved
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings:
    - statement: Keywords Autophagy, Apoptosis, and Translation regulation map to corresponding GO terms
- id: PMID:20537536
  title: DAP1, a novel substrate of mTOR, negatively regulates autophagy.
  findings:
    - statement: DAP1 is a direct substrate of mTOR
      supporting_text: "Here we identify death-associated protein 1 (DAP1) as a novel substrate of mTOR that negatively regulates autophagy."
    - statement: Phosphorylation at Ser3 and Ser51 by mTOR inactivates DAP1 autophagy suppression
      supporting_text: "DAP1 is functionally silenced in growing cells through mTOR-dependent phosphorylations on Ser3 and Ser51."
    - statement: DAP1 knockdown enhances autophagic flux
      supporting_text: "The link of DAP1 to autophagy was first apparent in that its knockdown enhanced autophagic flux"
    - statement: Dephosphorylated DAP1 actively suppresses autophagy during starvation
      supporting_text: "Inactivation of mTOR during starvation caused a rapid reduction in these phosphorylation sites and converted the protein into an active suppressor of autophagy."
    - statement: DAP1 acts as a "brake" to prevent autophagy overactivation
      supporting_text: "These results are consistent with a \"Gas and Brake\" model in which mTOR inhibition also controls a buffering mechanism that counterbalances the autophagic flux and prevents its overactivation under nutrient deprivation."
- id: PMID:7828849
  title: Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death.
  findings:
    - statement: DAP1 originally identified through functional cloning screen for IFN-gamma-induced cell death mediators
      supporting_text: "In this system we have identified two novel genes whose expression was indispensable for the execution of this type of cell death."
    - statement: DAP1 is a basic, proline-rich 15 kDa protein
      supporting_text: "One of those genes (DAP-1) is expressed as a single 2.4-kb mRNA that codes for a basic, proline-rich, 15-kD protein."
    - statement: Antisense RNA knockdown of DAP1 protected cells from IFN-gamma-induced programmed cell death
      supporting_text: "The antisense RNA-mediated inactivation of the two novel genes protected the cells from the IFN-gamma-induced cell death"
    - statement: DAP1 involvement is specific to programmed cell death, not necrosis or cytostatic effects
      supporting_text: "protected the cells from the IFN-gamma-induced cell death but not from the cytostatic effects of the cytokine or from a necrotic type of cell death"
- id: UniProtKB:P51397
  title: UniProt entry for human DAP1
  findings:
    - statement: DAP1 is an intrinsically disordered protein (entire 102 AA region)
      supporting_text: "Ribosome-binding protein involved in ribosome hibernation, a process during which ribosomes are stabilized in an inactive state and preserved from proteasomal degradation"
    - statement: Associates with ribosomes via eIF5A interaction at polypeptide exit tunnel
      supporting_text: "Acts via its association with eiF5a (EIF5A and EIF5A2) at the polypeptide exit tunnel of the ribosome, preventing mRNA translation (By similarity)."
    - statement: Involved in ribosome hibernation, particularly in oocytes
      supporting_text: "Involved in ribosome hibernation in the mature oocyte by preventing mRNA translation, leading to ribosome inactivation (By similarity)."
    - statement: Phosphorylation by mTOR at Ser3 and Ser51 inhibits autophagy suppression activity
      supporting_text: "Phosphorylated. Phosphorylation by MTOR inhibits the suppressive activity of DAP toward autophagy."
    - statement: Additional phosphorylation sites at Ser49 and Ser91 identified by mass spectrometry
      supporting_text: "Also acts as a negative regulator of autophagy"
- id: file:human/DAP/DAP-deep-research-falcon.md
  title: Deep research review of DAP1 gene function
  findings:
    - statement: DAP1 is an mTORC1-phosphoregulated intrinsically disordered cytoplasmic protein that suppresses autophagy when dephosphorylated
      supporting_text: "Human DAP1 (UniProt P51397) is an mTORC1-phosphoregulated, intrinsically disordered cytoplasmic protein that suppresses autophagy when dephosphorylated."
    - statement: Key regulatory sites Ser3 and Ser51 link nutrient signaling to autophagy control
      supporting_text: "Key regulatory sites (Ser3, Ser51) link nutrient signaling to autophagy control."
    - statement: DAP1 behaves as an intrinsically disordered protein with limited secondary structure propensity
      supporting_text: "Nearly complete 1H/13C/15N NMR chemical-shift assignments show limited spectral dispersion and minimal secondary-structure propensity (0% alpha-helix by shift-derived analysis), supporting a disordered state"

core_functions:
- description: >
    DAP1's primary characterized molecular function is as a negative regulator of autophagy.
    Under nutrient-rich conditions, mTORC1 phosphorylates DAP1 at Ser3 and Ser51, keeping it
    inactive. During starvation or mTOR inhibition, DAP1 is rapidly dephosphorylated and
    becomes an active suppressor of autophagy, acting as a "brake" to prevent overactivation
    of autophagic flux. This function is supported by strong experimental evidence
    (PMID:20537536) and represents the central role of DAP1 in cellular nutrient sensing.
  molecular_function:
    id: GO:0043022
    label: ribosome binding
  directly_involved_in:
    - id: GO:0010507
      label: negative regulation of autophagy
  supported_by:
    - reference_id: PMID:20537536
      supporting_text: "Here we identify death-associated protein 1 (DAP1) as a novel substrate of mTOR that negatively regulates autophagy."
    - reference_id: file:human/DAP/DAP-deep-research-falcon.md
      supporting_text: "Core biochemical function: DAP1 is a negative regulator of autophagy and a direct substrate of mTORC1."
- description: >
    DAP1 functions in ribosome hibernation through its ribosome-binding activity and
    interaction with eIF5A at the polypeptide exit tunnel. This prevents mRNA translation
    and keeps ribosomes in an inactive, protected state. This function is particularly
    important in oocytes where ribosomes produced during oogenesis are stored and
    translationally repressed until needed in early embryonic development.
  molecular_function:
    id: GO:0043022
    label: ribosome binding
  directly_involved_in:
    - id: GO:0141014
      label: ribosome hibernation
  supported_by:
    - reference_id: UniProtKB:P51397
      supporting_text: "Ribosome-binding protein involved in ribosome hibernation, a process during which ribosomes are stabilized in an inactive state and preserved from proteasomal degradation (By similarity)."

proposed_new_terms: []

suggested_questions:
- question: >
    What is the precise molecular mechanism by which dephosphorylated DAP1 suppresses
    autophagy? Does it directly interact with ATG proteins or act through intermediate
    effectors? While DAP1's role as an autophagy suppressor is well-established, the
    downstream molecular targets of active (dephosphorylated) DAP1 remain incompletely
    characterized. Recent work suggests involvement of the ATG16L1-LC3 axis but direct
    binding partners have not been fully defined.
- question: >
    Is DAP1's ribosome hibernation function in human cells as significant as in zebrafish,
    and does it operate in cell types beyond oocytes? The ribosome hibernation function
    is primarily characterized from zebrafish studies and inferred by sequence similarity.
    Direct experimental evidence in human cells and non-oocyte contexts would strengthen
    these annotations.
- question: >
    How does DAP1 contribute to the crosstalk between autophagy and apoptosis, and is
    its original identification as a cell death mediator a direct or indirect effect?
    The relationship between DAP1's autophagy-suppressive function and its role in
    IFN-gamma-induced cell death remains unclear.

suggested_experiments:
- description: >
    Co-immunoprecipitation and proximity ligation assays to identify direct binding
    partners of dephosphorylated DAP1 in the autophagy machinery. This would clarify
    the molecular mechanism of autophagy suppression and potentially justify more
    specific molecular function annotations.
- description: >
    Ribosome profiling and eIF5A co-localization studies in human cell lines under
    various nutrient conditions. This would provide direct experimental evidence for
    human DAP1's ribosome hibernation function, currently supported only by similarity
    to zebrafish ortholog.